Detalhe da pesquisa
1.
Practical Guidance on Effective Basal Insulin Titration for Primary Care Providers.
Clin Diabetes
; 37(4): 368-376, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31660010
2.
The Relevance of Clinical Pharmacology Studies of Basal Insulins to Primary Care.
J Fam Pract
; 68(1 Suppl)2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30677105
3.
Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are Different.
Adv Ther
; 36(5): 1018-1030, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30929185
4.
Higher concentration insulins: an overview of clinical considerations.
Postgrad Med
; 129(5): 554-562, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28475455
5.
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, for the management of type 2 diabetes.
Hosp Pract (1995)
; 42(3): 96-108, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25255411
6.
Weight change in patients with type 2 diabetes starting basal insulin therapy: correlates and impact on outcomes.
Postgrad Med
; 126(6): 93-105, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25414938
7.
A short-acting GLP-1 analog or prandial insulin to supplement basal insulin?--Moving toward personalized management of type 2 diabetes mellitus.
Postgrad Med
; 126(3): 135-44, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24918799
8.
Integrating advances in insulin into clinical practice: Effective utilization of insulin in patient management.
J Fam Pract
; 62(9 Suppl Insulin): S18-31, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24080570
9.
A practice-based research network focused on comparative effectiveness research in type 2 diabetes management.
Postgrad Med
; 125(3): 172-80, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23748518
10.
The importance and treatment of postprandial hyperglycemia.
J Fam Pract
; 59(5 Suppl): S9-14, 2010 May.
Artigo
Inglês
| MEDLINE | ID: mdl-20544057
11.
Distinguishing among incretin-based therapies. Glucose-lowering effects of incretin-based therapies.
J Fam Pract
; 59(9 Suppl 1): S10-9, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20824235
12.
Distinguishing among incretin-based therapies. Patient education and self-management.
J Fam Pract
; 59(9 Suppl 1): S28-30, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20824237
13.
Distinguishing among incretin-based therapies. Safety, tolerability, and nonglycemic effects of incretin-based therapies.
J Fam Pract
; 59(9 Suppl 1): S20-7, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20824236
14.
Distinguishing among incretin-based therapies. Pathophysiology of type 2 diabetes mellitus: potential role of incretin-based therapies.
J Fam Pract
; 59(9 Suppl 1): S5-9, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20824239
15.
Distinguishing among incretin-based therapies. Introduction.
J Fam Pract
; 59(9 Suppl 1): S3-4, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20824238
16.
Options for intensifying diabetes treatment.
J Fam Pract
; 60(9 Suppl): S7-10, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21912777